Skip to main content

Stem cells for Duchenne?

Adult stem cells taken from humans suffering from Duchenne muscular dystrophy can be genetically modified and used to treat the disease in a mouse model, researchers linkurl:report;https://www.cellstemcell.com/ today in Cell Stem Cell. Duchenne muscular dystrophy is a progressive condition caused by a mutation on the X chromosome that leads to a lack of dystrophin protein in muscle. The mutation is usually caused by a deletion or mutation in the gene, leading to a shift in the reading frame of m

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Adult stem cells taken from humans suffering from Duchenne muscular dystrophy can be genetically modified and used to treat the disease in a mouse model, researchers linkurl:report;https://www.cellstemcell.com/ today in Cell Stem Cell. Duchenne muscular dystrophy is a progressive condition caused by a mutation on the X chromosome that leads to a lack of dystrophin protein in muscle. The mutation is usually caused by a deletion or mutation in the gene, leading to a shift in the reading frame of mRNA translation. In past studies, injecting Duchenne mice with normal muscle cells has temporarily staved off disease symptoms, but that technique does not work reliably and can cause immune rejection. So researchers have linkurl:proposed;https://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=16691118&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum delivering muscle progenitor cells instead. Yvan Torrente of the University of Milan, Italy, and colleagues took human blood- and muscle-derived stem cells from Duchenne patients. They used linkurl:antisense oligonucleotides;https://www.the-scientist.com/article/display/21438/ delivered by linkurl:lentiviral vectors;https://www.the-scientist.com/article/display/19298/ to mask the incorrect mRNA splicing sites, thus returning translation to its normal reading frame. They then intramuscularly injected the corrected cells into the sick mice. Within three weeks, the transplanted cells gave rise to muscle fibers and spurred production of the dystrophin protein. The authors caution, however, that using viral vectors may cause tumor formation, and that details of the technique such as its efficiency remain to be worked out. Both the antisense techniques and muscle cell transplantation have been tried before in Duchenne, note linkurl:Kay Davis;https://www.hertford.ox.ac.uk/main/content/view/155/249/ of Oxford University and linkurl:Miranda Grounds;https://school.anhb.uwa.edu.au/personalpages/grounds/ of the University of Western Australia in an accompanying review article. But the combination of the two makes this a proof of principle study that shows that "steady progress is being made toward the goal of stem cell-mediated restoration of dystrophin expression," they write.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo